The Traderszone Network

Published in TZ Latest News 21 September, 2017 by The TZ Newswire Staff

Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

Basel, September 22, 2017
Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid leukemia (CML), gastrointestinal tumors (GIST) and other rare cancers. The two organizations have been long-time collaborators in providing access to care for patients in lower-income countries through the Glivec International Patient Assistance Program (GIPAP), one of the most innovative patient assistance programs ever implemented on a global scale.